IE
SANA icon

Israel Englander’s Sana Biotechnology SANA Stock Holding History

Israel Englander’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-150,000
Closed -$624K – 6403
2024
Q3 		$624K Buy
150,000
+99,500
+197% +$523K ﹤0.01% 4654
2024
Q2 		$276K Buy
+50,500
New +$402K ﹤0.01% 4961

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Israel Englander's SANA Position: Q2 2026 in Review

Israel Englander reduced its Sana Biotechnology (SANA) stake by 59% in Q2 2026, selling an estimated $3.02M and leaving 653,503 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3712.

Israel Englander first reported a position in SANA in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.96M in Q4 2023. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Israel Englander held 653,503 shares of Sana Biotechnology worth $2.28M as of Q2 2026.
  • Israel Englander sold 937,527 Sana Biotechnology shares in Q2 2026, an estimated $3.02M.
  • Sana Biotechnology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3712 holding.
  • Israel Englander first reported a position in Sana Biotechnology in Q4 2021 and has held it in 18 quarters since.
  • Israel Englander's Sana Biotechnology position peaked at $8.96M in Q4 2023.
  • 208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.